<p>(A) Immunofluorescence staining of αSMA for TGFβ1-treated NMuMG cells on 1600 μm<sup>2</sup> islands with shape factors 1 and 8. (B) Quantification of the percentage of NMuMG cells expressing αSMA on islands with shape factors 1 and 8 after a 48 h treatment with or without TGFβ1. *p < 0.05, **p < 0.01. Scale bars, 20 μm. </p
<p><b>A</b>) KGN cells were treated with or without TGFα for 48 hours and cell viability was detecte...
<p>(a) Sub-confluent NHU cells were treated with or without PD153035 (1 µM), TGFβ (2 ng/ml) or SB431...
(A) Measurement of pharmacological inhibitors on TGFβ1 signaling. Cells were pretreated with the ind...
<p>(A) Fluorescence staining for F-actin in TGFβ1-treated NMuMG cells cultured on 400 μm<sup>2</sup>...
<p>(A) Immunofluorescence staining for nuclei and MRTF-A in TGFβ1-treated NMuMG cells cultured on 40...
<p>(A) Phase contrast images of NMuMG cells treated with and without TGFβ1. Quantification of (B) p...
<p>A: Untreated Eca109 and KYSE150 cells, 100×; B,C: Eca109 and KYSE150 cells treated with TGF-β1 (1...
<p>(A) Immunofluorescence staining of αSMA, caldesmon, and tropomyosin for TGFβ1-treated cells cultu...
<p>(a) Phase-contrast micrographs of NHU cell cultures at confluence following growth for 6 days in ...
(A) Relative mRNA expression levels of NCAM isoforms (NCAM-120, NCAM-140, NCAM-180) and FGFR1 at the...
<p>(A) Morphological alterations of 603B cells induced by TGF-β1 (3 ng/ml) at indicated time points....
<p>(a and b) Representative RT-PCR (a) and Western blot results (b) show that TGF-β1 induced express...
<p>(<b>A</b>) Cells were stimulated for 30 min with TGF-β1 (0.1 ng/ml; 1.0 ng/ml), BMP-7 (25 ng/ml) ...
<p>(A) HuH7 cells and primary HCC tumour cells were treated with TGF-β for 48h and the expression of...
<p><b>A and B</b>, Representative fluorescent images of naive (control) and differentiated (TGF-β1-t...
<p><b>A</b>) KGN cells were treated with or without TGFα for 48 hours and cell viability was detecte...
<p>(a) Sub-confluent NHU cells were treated with or without PD153035 (1 µM), TGFβ (2 ng/ml) or SB431...
(A) Measurement of pharmacological inhibitors on TGFβ1 signaling. Cells were pretreated with the ind...
<p>(A) Fluorescence staining for F-actin in TGFβ1-treated NMuMG cells cultured on 400 μm<sup>2</sup>...
<p>(A) Immunofluorescence staining for nuclei and MRTF-A in TGFβ1-treated NMuMG cells cultured on 40...
<p>(A) Phase contrast images of NMuMG cells treated with and without TGFβ1. Quantification of (B) p...
<p>A: Untreated Eca109 and KYSE150 cells, 100×; B,C: Eca109 and KYSE150 cells treated with TGF-β1 (1...
<p>(A) Immunofluorescence staining of αSMA, caldesmon, and tropomyosin for TGFβ1-treated cells cultu...
<p>(a) Phase-contrast micrographs of NHU cell cultures at confluence following growth for 6 days in ...
(A) Relative mRNA expression levels of NCAM isoforms (NCAM-120, NCAM-140, NCAM-180) and FGFR1 at the...
<p>(A) Morphological alterations of 603B cells induced by TGF-β1 (3 ng/ml) at indicated time points....
<p>(a and b) Representative RT-PCR (a) and Western blot results (b) show that TGF-β1 induced express...
<p>(<b>A</b>) Cells were stimulated for 30 min with TGF-β1 (0.1 ng/ml; 1.0 ng/ml), BMP-7 (25 ng/ml) ...
<p>(A) HuH7 cells and primary HCC tumour cells were treated with TGF-β for 48h and the expression of...
<p><b>A and B</b>, Representative fluorescent images of naive (control) and differentiated (TGF-β1-t...
<p><b>A</b>) KGN cells were treated with or without TGFα for 48 hours and cell viability was detecte...
<p>(a) Sub-confluent NHU cells were treated with or without PD153035 (1 µM), TGFβ (2 ng/ml) or SB431...
(A) Measurement of pharmacological inhibitors on TGFβ1 signaling. Cells were pretreated with the ind...
DOI
Add to ORKG